PodParley PodParley
GPH 75: Tuberculosis

EPISODE · Mar 30, 2026 · 57 MIN

GPH 75: Tuberculosis

from Clinical Deep Dives · host Dr Manaan Kar Ray

Tuberculosis (TB) remains one of the leading infectious causes of death worldwide, despite being preventable and treatable. Caused by Mycobacterium tuberculosis, it spreads primarily through airborne transmission and disproportionately affects low- and middle-income countries.This episode examines:• Global epidemiology and high-burden regions• Latent versus active tuberculosis• Risk factors - HIV co-infection, malnutrition, overcrowding• Drug-sensitive and multidrug-resistant TB (MDR-TB)• Diagnostic strategies and laboratory capacity• Directly observed therapy and treatment adherence• Social determinants and housing conditions• TB in prisons and marginalised populations• Global End TB strategies and elimination goalsTuberculosis highlights the enduring link between infectious disease and social inequality. Crowded housing, poor ventilation, undernutrition, and limited access to care sustain transmission cycles. While modern diagnostics and treatment regimens have improved outcomes, drug resistance poses a significant threat.The episode explores both biomedical and structural responses - recognising that TB control requires strengthened health systems, poverty reduction, and sustained global coordination.Tuberculosis persists not because it cannot be treated, but because its determinants extend beyond medicine.────────────────────────────Key Takeaways• Tuberculosis remains a leading cause of infectious mortality• Latent infection creates a large reservoir of potential disease• HIV co-infection significantly increases risk• Drug-resistant TB complicates treatment efforts• Early detection and treatment adherence are critical• Social determinants drive transmission patterns• Global elimination requires coordinated international effort This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit drmanaankarray.substack.com/subscribe

NOW PLAYING

GPH 75: Tuberculosis

0:00 57:28

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

Oncology Today with Dr Neil Love Research To Practice Medical oncologist Dr Neil Love interviews clinical investigators on new research and practical application to general medical oncology practice. My Take On It with Your Angelic Karma® Your Angelic Karma Here we take a look at how the United States measures alongside other First World Nations. + taking a deep dive into the science -The Report Metagenics Institute Podcast Metagenics Welcome to the Metagenics Institute Podcast where Healthcare Practitioners can hear innovative, cutting-edge information from leading experts from around the world. Join your host, Nathan Rose, to explore the latest evidence in Natural Health, challenge and debunk industry myths and offer practical, tangible, clinical tools which will transform your practice. The Syndicate Blogcast: Startups | Startup Investing | Tech News | Angel Investors | VC | Venture Capital | Private Equity | Crowdfunding | Fundraising Matt Ward - Serial Entrepreneur | Angel Investor | Startup Advisor | Amazon Ecommerce The Syndicate Blogcast show is an extension of The Syndicate podcast, featuring long form articles on the future technology, ecommerce, business and life. The mini-sodes deconstruct high level startup, business and tech issues to help investors and operators better understand and win the market. Recurring topics include: Facebook, Google, Amazon, Apple, Ecommerce, Blockchains, ICOs, Cryptocurrencies, Marketing, Fundraising, Venture Capital, Startup Challenges, Business Development and more. The Blogcast comes in addition to The Syndicate - the place where investors and startups combine to create crazy businesses and even crazier returns. The Syndicate podcast is a deep dive on the angel investors and VCs behind the big name startups. We interview the best and brightest investors, syndicate leads, GPs, limited partners and startup founders to create an original, off the cuff discussion on startup investing.
URL copied to clipboard!